O’Melveny represented TYK Medicines in the transaction. TYK Medicines, Inc. (2410.HK) executed its initial public offering and listing on the Main Board of the Hong Kong...
TYK Medicines’ US$74 Million Hong Kong IPO
Adlai Nortye’s US$100 Million Initial Public Offering
O’Melveny represented Adlai Nortye Ltd. in the transaction. Adlai Nortye Ltd. (NASDAQ: ANL) announced its IPO on the Nasdaq. Adlai Nortye expects to receive aggregate gross...
Jenscare Scientific’s Hong Kong IPO
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...